Five years in figures

Net salesEUR million1,129.81,248.41,254.31,116.21,090.4
   of which outside FinlandEUR million1,024.01,136.01,142.01,021.9977.5
   in percent of net sales   %90.691.091.091.589.6
   export from FinlandEUR million21.220.424.220.120.2
Change of net sales, %   %-9.5-0.512.42.4-2.5
Gross profitEUR million511.4555.9539.8452.0447.3
   % of net sales   %45.344.543.040.541.0
  % of net sales%8.710.811.48.85.5
Comparable EBITEUR
Comparable EBITDAEUR
Change in fair value of biological assetsEUR million4.
Financial items netEUR million-24.0-11.70.0-8.93.4
  % of net sales   %-2.1-0.90.0-0.80.3
Profit before taxesEUR million79.7124.1144.189.863.2
  % of net sales   %7.19.911.58.05.8
Income taxEUR million-9.7-25.0-56.5-21.3-10.8
Profit for the period attributable to the equity
holders in the parent company
EUR million69.998.286.667.651.7
   % of net sales   %
Non-controlling interestsEUR million0.
Employee benefitsEUR million289.2289.0293.7262.9311.9
Depreciation, amortization and impairmentEUR million66.059.461.676.159.6
   % of net sales   %
Cash flow from operating activitiesEUR million220.8-61.4122.9199.296.5
Capital expenditureEUR million50.848.134.430.040.0
   % of net sales   %
Research and development costs in income statementEUR million19.820.815.516.518.4
   % of net sales   %
Equity attributable to equity holders of the parent companyEUR million819.9831.6812.1757.8760.9
Non-controlling interestEUR million3.
Equity totalEUR million823.7835.6816.3761.6764.5
Net interest-bearing debtEUR million446.7325.3144.4143.7261.1
Net debt/LTM EBITDA excl. IACratio2.541.550.670.781.91
Working capitalEUR million304.2337.2164.5134.2194.4
Balance sheet totalEUR million1,754.91,585.41,435.51,342.01,364.3
Return on investment   %8.712.
Return on equity   %8.412.
Equity ratio   %46.952.756.956.856.0
Net gearing   %54.238.917.718.934.2
Personnel (FTE), average 6,1336,2736,0816,1046,840
Personnel, end of period 7,1626,5956,6906,4116,984
   of which outside Finland 6,0845,4325,5795,3485,852